Cleara Biotech key facts
- Operator of a biotechnology company intended to eliminate senescent cells to treat age-related pathologies.
- It has raised $5.0M; the latest was Later Stage VC in Feb 2026.
- Notable investors include FJ Labs, TA Ventures, ROM Utrecht Region, Infinitas Capital, TruVenturo — 11 tracked in total.
- Status: Privately Held (backing).
Who backs Cleara Biotech
11+Membership and data by Private Market View
- ·The complete investor list: 11 names
- ·Watch Cleara Biotech: the Monday email on marks, rounds and moves
Cleara Biotech funding rounds
No funding rounds for Cleara Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Cleara Biotech investors
11 investors are on record for Cleara Biotech, including FJ Labs, TA Ventures, ROM Utrecht Region and Infinitas Capital.
About Cleara Biotech
Operator of a biotechnology company intended to eliminate senescent cells to treat age-related pathologies. The company offers therapeutics that can be used to remove senescence-like cancer cells that are a cause of therapy resistance in terminal cancer, enabling physicians to treat their patients effectively.
- Sector
- Healthcare
- HQ
- Utrecht, Netherlands
- Founded
- 2018
- Employees
- 9
- Website
- clearabiotech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Cleara Biotech doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.